Quarterly report pursuant to Section 13 or 15(d)

Segment Information (Restated) (Tables)

v3.23.1
Segment Information (Restated) (Tables)
3 Months Ended
Jul. 02, 2022
Segment Reporting [Abstract]  
Schedule of Segment Information

The following tables present our segment information for the 26 weeks ended July 2, 2022 and July 3, 2021 (in $000's):

 

 

 

Thirteen Weeks Ended

 

 

Twenty Six Weeks Ended

 

 

 

July 2, 2022

 

 

July 3, 2021

 

 

July 2, 2022

 

 

July 3, 2021

 

 

 

(as restated)

 

 

 

 

 

(as restated)

 

 

 

 

Revenues

 

 

 

 

 

 

 

 

 

 

 

 

Biotechnology

 

$

 

 

$

 

 

$

 

 

$

 

Recycling

 

 

10,538

 

 

 

8,606

 

 

 

19,862

 

 

 

17,278

 

Discontinued operations

 

 

 

 

 

 

 

 

 

 

 

 

Total Revenues

 

$

10,538

 

 

$

8,606

 

 

$

19,862

 

 

$

17,278

 

Gross profit

 

 

 

 

 

 

 

 

 

 

 

 

Biotechnology

 

$

 

 

$

 

 

$

 

 

$

 

Recycling

 

 

1,649

 

 

 

1,743

 

 

 

3,502

 

 

 

3,164

 

Discontinued operations

 

 

 

 

 

 

 

 

 

 

 

 

Total Gross profit

 

$

1,649

 

 

$

1,743

 

 

$

3,502

 

 

$

3,164

 

Operating Income (loss)

 

 

 

 

 

 

 

 

 

 

 

 

Biotechnology

 

$

(110

)

 

$

(808

)

 

$

(352

)

 

$

(1,050

)

Recycling

 

 

(1,147

)

 

 

(1,099

)

 

 

(1,993

)

 

 

(2,027

)

Operating loss from continuing operations

 

 

(1,257

)

 

 

(1,907

)

 

 

(2,345

)

 

 

(3,077

)

Discontinued operations

 

 

10,239

 

 

 

(945

)

 

 

10,235

 

 

 

(1,884

)

Total Operating income (loss)

 

$

8,982

 

 

$

(2,852

)

 

$

7,890

 

 

$

(4,961

)

Depreciation and amortization

 

 

 

 

 

 

 

 

 

 

 

 

Biotechnology

 

$

 

 

$

 

 

$

 

 

$

 

Recycling

 

 

137

 

 

 

110

 

 

 

268

 

 

 

218

 

Depreciation and amortization from continuing operations

 

 

137

 

 

 

110

 

 

 

268

 

 

 

218

 

Discontinued operations

 

 

 

 

 

935

 

 

 

2

 

 

 

1,872

 

Total Depreciation and amortization

 

$

137

 

 

$

1,045

 

 

$

270

 

 

$

2,090

 

Interest expense, net

 

 

 

 

 

 

 

 

 

 

 

 

Biotechnology

 

$

 

 

$

 

 

$

 

 

$

 

Recycling

 

 

61

 

 

 

125

 

 

 

253

 

 

 

198

 

Discontinued operations

 

 

 

 

 

 

 

 

 

 

 

 

Total Interest expense, net

 

$

61

 

 

$

125

 

 

$

253

 

 

$

198

 

Net income (loss) before benefit from income taxes

 

 

 

 

 

 

 

 

 

 

 

 

Biotechnology

 

$

(110

)

 

$

(808

)

 

$

(352

)

 

$

(1,050

)

Recycling

 

 

(1,363

)

 

 

(2,992

)

 

 

127

 

 

 

(1,353

)

Net loss before benefit from income taxes

 

 

(1,473

)

 

 

(3,800

)

 

 

(225

)

 

 

(2,403

)

Discontinued operations

 

 

10,351

 

 

 

(974

)

 

 

10,317

 

 

 

(1,871

)

Total Net income (loss) before benefit from income taxes

 

$

8,878

 

 

$

(4,774

)

 

$

10,092

 

 

$

(4,274

)

 

 

 

 

As of
July 2,
2022

 

 

As of
January 1,
2022

 

Assets

 

 

 

 

 

 

Biotechnology

 

$

 

 

$

 

Recycling

 

 

25,706

 

 

 

15,058

 

Discontinued operations

 

 

 

 

 

107

 

Total Assets

 

$

25,706

 

 

$

15,165

 

 

 

 

 

 

 

 

Intangible assets

 

 

 

 

 

 

Biotechnology

 

$

 

 

$

 

Recycling

 

 

345

 

 

 

268

 

Discontinued operations

 

 

 

 

 

 

Total Intangible assets

 

$

345

 

 

$

268